electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

8/1/23 8:00:00 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $ECOR alert in real time by email

ROCKAWAY, N.J., Aug. 01, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ:ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial results for the second quarter ended June 30, 2023, after the close of the market on Wednesday, August 9, 2023. Management will host a conference call and webcast at 4:30 PM EDT to discuss the financial results and answer questions.

Wednesday, August 9, 2023, 4:30 PM EDT

Domestic: 877-407-8835

International: +1 201-689-8779

Conference ID: 13739200

Webcast: electroCore Earnings Webcast

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation ("nVNS") technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.

For more information, visit www.electrocore.com.

Contact:

ECOR Investor Relations

(973) 302-9253

[email protected]

Get the next $ECOR alert in real time by email

Date	Price Target	Rating	Analyst
1/19/2022	$3.00 → $2.75	Buy	HC Wainwright & Co.
7/27/2021	$3.00	Buy	Ladenburg Thalmann

electroCore to Announce Second Quarter Financial Results on Wednesday, August 9

Chat with this insight

Recent Analyst Ratings for $ECOR

$ECOR Financials

Live finance-specific insights

electroCore Announces Third Quarter 2024 Financial Results

electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024

Ecora Resources PLC Announces Half year results

$ECOR Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

HC Wainwright & Co. reiterated coverage on electroCore with a new price target

Ladenburg Thalmann initiated coverage on electroCore with a new price target

Maxim Group resumed coverage on electroCore with a new price target

$ECOR Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13D/A filed by electroCore Inc. (Amendment)

SEC Form SC 13G/A filed by electroCore Inc. (Amendment)

SEC Form SC 13D filed by electroCore Inc.

$ECOR Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

$ECOR SEC Filings

$ECOR Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$ECOR Insider purchases explained

Analytical look into recent insider purchases

$ECOR Market Insights

Live Market Insights

Director Errico Thomas J. bought $30,595 worth of shares (5,000 units at $6.12), increasing direct ownership by 2% to 233,818 units (SEC Form 4)

Director Gandolfo John P bought $6,430 worth of shares (1,000 units at $6.43), increasing direct ownership by 2% to 50,704 units (SEC Form 4)

Goldberger Daniel S bought $247,587 worth of shares (38,505 units at $6.43), increasing direct ownership by 18% to 249,565 units (SEC Form 4)

SEC Form D filed by electroCore Inc.

SEC Form 10-Q filed by electroCore Inc.

electroCore Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

New insider Lev Joshua S. claimed ownership of 16,333 shares (SEC Form 3)

SEC Form 4 filed by Director Goldstein Julie Ann

SEC Form 4 filed by Director Cuneo F Peter

Stock Movement: Insider Purchase at electroCore Inc. on Jun 6

ElectroCore Files For Offering Of Up To 1.9M Shares By The Selling Securityholders

electroCore Announces The Commercial Launch Of TAC-STIM, A Non-Invasive Vagus Nerve Stimulator

electroCore To Join Russell Microcap Index Effective After Close On Jun. 28

$ECOR Press Releases

Fastest customizable press release news feed in the world

electroCore's Truvaga™ Plus Wins Woman's World Magazine 50 over 50 Award

electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

$ECOR Leadership Updates

Live Leadership Updates

electroCore to Join Russell Microcap® Index

Firefly Neuroscience, an AI-Driven Brain Health Company, Names Brian S. Posner to its Board of Directors, Upon Closing of Its Merger Transaction with WaveDancer

electroCore Announces Changes to its Board of Directors

Recent Analyst Ratings for
$ECOR

$ECOR
Financials

$ECOR
Analyst Ratings

$ECOR
Large Ownership Changes

$ECOR
Insider Purchases

$ECOR
SEC Filings

$ECOR
Insider Trading

$ECOR
Insider purchases explained

$ECOR
Market Insights

$ECOR
Press Releases

$ECOR
Leadership Updates